本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Y-mAbs Therapeutics, Inc.

4.69
+0.15003.30%
盤後4.690.00000.00%16:40 EDT
成交量:10.70萬
成交額:49.63萬
市值:2.12億
市盈率:-7.00
高:4.73
開:4.52
低:4.51
收:4.54
資料載入中...

公司資料

公司名字:
Y-mAbs Therapeutics, Inc.
交易所:
NASDAQ
成立時間:
2015
員工人數:
104
公司地址:
202 Carnegie Center,Suite 301,Princeton,New Jersey,United States
郵編:
08540
傳真:
- -
簡介:
Y-mAbs Therapeutics, Inc.於2015年4月30日根據特拉華州法律註冊成立。該公司是一家商業化階段的生物製藥公司,專註於新型放射免疫療法和基於抗體的治療產品的開發和商業化,用於治療癌症。該公司正在利用專有的放射免疫療法和抗體平台和專業知識來開發廣泛的創新藥物組合。

董事

名稱
職位
Claus Juan Moller San Pedro
Chief Executive Officer and Director
Thomas Gad
Founder, Chairman of the Board of Director, President, Head of Business Development
Bo Kruse
Executive Vice President, Secretary, Treasurer, Chief Financial Officer and Director
Ashutosh Tyagi
Director
David N. Gill
Director
Gregory Raskin
Director
James I. Healy
Director
Johan Wedell Wedellsborg
Director
Michael Buschle
Director

股東

名稱
職位
Claus Juan Moller San Pedro
Chief Executive Officer and Director
Joris Wiel Jan Wilms
Senior Vice President and Chief Operating Officer
Bo Kruse
Executive Vice President, Secretary, Treasurer, Chief Financial Officer and Director
Steen Lisby
Senior Vice President and Chief Medical Officer
Torben Lund Hansen
Senior Vice President and Head of Technical Operations
Thomas Gad
Founder, Chairman of the Board of Director, President, Head of Business Development